InsiderSignal.AI

InsiderSignal.ai

ONCO - Onconetix, Inc.

Insider Sale by Hrt Financial LP (10%)

1 Month
After Trade
Before Trade

Loading data...

Trade Summary

Yesterday, Hrt Financial LP, serving as 10% owner at Onconetix, Inc. (ONCO), sold 49,710 shares at $0.69 per share, for a total transaction value of $34,300.00. Following this transaction, Hrt Financial LP now holds 33,649 shares of ONCO.

This sale represents a 60.00% decrease in Hrt Financial LP's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Tuesday, April 21, 2026 and publicly disclosed via SEC Form 4 filing on Wednesday, April 22, 2026, 1 day after the trade was made.

Onconetix, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.

Hrt Financial LP

Hrt Financial LP

10%

HRT Financial LP is a quantitative trading and market‑making firm registered as a broker‑dealer and institutional investment manager, operating as an affiliate of Hudson River Trading and based at 3 World Trade Center, 175 Greenwich Street, New York, NY 10007.[[4]](https://www.nasdaq.com/market-activity/institutional-portfolio/hrt-financial-lp-851971)[[5]](https://brokercheck.finra.org/firm/summary/152144) The partnership manages a diversified institutional portfolio across thousands of U.S. securities, with recent regulatory filings disclosing more than 2,700 positions and a portfolio value reported in the tens of millions of dollars, and it has acted as a significant (10%+) corporate insider in issuers such as Akanda Corp. (AKAN) through its trading activities.[[1]](https://fintel.io/i/hrt-financial-llc)[[4]](https://www.nasdaq.com/market-activity/institutional-portfolio/hrt-financial-lp-851971) Formed via a conversion from a Delaware limited liability company to a Delaware limited partnership in 2020, HRT Financial LP functions as one of the trading entities through which the broader Hudson River Trading group executes its high‑frequency and quantitative strategies on U.S. markets.[[6]](https://www.sec.gov/Archives/edgar/data/1475597/000126312821000004/STMTNOTES.pdf)[[2]](https://www.hudsonrivertrading.com) Through its affiliation with Hudson River Trading (HRT), HRT Financial LP participates in a global, multi‑asset class trading operation that provides liquidity on electronic markets worldwide using advanced automated trading algorithms.[[2]](https://www.hudsonrivertrading.com)[[3]](https://www.hudsonrivertrading.com/about/) Hudson River Trading, founded in 2002 by partners with computer science and mathematics backgrounds from institutions such as Harvard and MIT, has grown into a large technology‑driven trading organization employing specialists in mathematics, computer science, statistics, physics, and engineering, and is recognized as a prominent advocate for fair and transparent markets.[[3]](https://www.hudsonrivertrading.com/about/)[[2]](https://www.hudsonrivertrading.com)

View full insider profile →

Trade Price

$0.69

Quantity

49,710

Total Value

$34,300.00

Shares Owned

33,649

Trade Date

Tuesday, April 21, 2026

1 days ago

SEC Filing Date

Wednesday, April 22, 2026

Filed 1 day after trade

HEALTHCAREBIOTECHNOLOGY

About Onconetix, Inc.

Company Overview

No company information available
View news mentioning ONCO

💬 Want Deeper Insight?

Use our AI assistant to ask questions about this trade, the insider, or the company.

Chat with AI

Share this trade

https://insidersignal.ai/trade/5850554

🚀 Track Insider Trades in Real-Time

Create a free account to access our full database of insider trades, AI-powered analysis, price alerts, and discover what corporate executives are buying and selling.

Create Free AccountLearn More

✓ Free forever plan available  •  ✓ No credit card required  •  ✓ Cancel anytime